New data from the accounting platform Xero should give American entrepreneurs one more reason to be optimistic about 2025.

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the final quarter of ...

Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

Fast-food restaurant owner Yum Brands is expecting stronger sales growth this year after it moves past challenges in its Middle East markets.

International Business Machines Corp. gave a stronger-than-expected revenue growth outlook for the coming years led by the ...

The Danish pharmaceutical company expects sales growth to slow this year as capacity constraints, intensifying competition ...

Estee Lauder will lay off between 5,800 and 7,000 employees after second-quarter sales plummeted 6% and operating income ...

Chipotle Mexican Grill said on Tuesday that if President Donald Trump's proposed tariffs on Mexico go into full effect, the ...

Chipotle reduced its financial outlook for same-store sales this year to an increase in the low to mid-single digits.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Yum! Brands Inc. sales surpassed expectations, powered by growth at Taco Bell as the fast-food chain continues to sidestep a slowdown that has plagued many competitors.

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.